Botulinum toxin A in children with cerebral palsy: Evaluation of therapy using the Pediatric Evaluation of Disability Inventory (PEDI)

Journal of Pediatric Neurology

Volumn 1, Issue 1, 2003, Pages 29-34

  Mall, Volker ^a   Kirschner, Janbernd ^a   Linder, Michaela ^a   Schindler, Gudrun ^a   Berweck, Steffen ^b   Stein, Sabine ^a   Michaelis, Ulla ^a   Bernius, Peter ^c   Korinthenberg, Rudolf ^a   Heinen, Florian ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c City Hospital Munich Harlaching   (Germany)

Author keywords

Botulinum toxin A; Cerebral palsy; PEDI; Pediatric Evaluation of Disability Inventory; Therapy evaluation

Indexed keywords

EID: 85013588165     PISSN: 13042580     EISSN: 13050613     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mall V, Heinen F, Linder M, Philipsen A, Korinthenberg R. Treatment of cerebral palsy with botulinum toxin A: functional benefit and reduction of disability. Three case reports. Pediatr Rehabil 1997; 1: 235-237.
2. Heinen F, Wissel J, Philipsen A, et al. Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics 1997; 28: 307-313.
3. Corry IS, Cosgrove AP, Walsh EG, McClean D. Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997; 39: 185-193.
4. Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary. randomized. double-blind trial. J Pediatr Orthop 1994; 14: 299-303.
5. Koman LA, Mooney JF 3rd, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized doubleblind placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000; 20: 108-115.
6. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999; 10:1-9.
7. Yang TF, Chan RC, Chuang TY, Liu TJ, Chiu JW. Treatment of cerebral palsy with botulinum toxin:evaluation with gross motor function measure. J Formos Med Assoc 1999; 98: 832-836.
8. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
9. Ketelaar M, Vermeer A, Helders PJ. Functional motor abilities of children with cerebral palsy:a systematic literature review of assessment measures. Clin Rehabil 1998; 12: 369-380.
10. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989; 31: 341-352.
11. Haley SM, Coster WJ, Ruth MF. A content validity study of the pediatric evaluation of disability inventory. Pediatr Phys Ther 1991; 3: 177-184.
12. Abel MF, Damiano DL, Pannunzio M, Bush J. Muscle-tendon surgery in diplegic cerebral palsy:functional and mechanical changes. J Pediatr Orthop 1999; 19: 366-375.
13. Almeida GL, Campbell SK, Girolami GL, Penn RD, Corcos DM. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Phys Ther 1997; 77: 751-764.
14. Bower E, McLellan D, Arney J, Campell MJ. A randomised controlled trial of different intensities of physiotherapy and different goal-setting procedures in 44 children with cerepral palsy. Dev Med Child Neurol 1996; 38: 226-237.
15. Flett PJ, Stern LM, Waddy H, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999; 35: 71-77.
16. Graveline C, Hwang P, Bone G, et al. Evaluation of gross and fine motor functions in children with hemidecortication: predictors of outcomes and timing of surgery. J Child Neurol 1999; 14: 304-315.
17. Heinen F, Linder M, Mall V, et al. Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A - the parents’ view of functional outcome. Eur J Neurol 1999; 6:47-50.
18. Hodgkinson I, Berard C, Jindrich ML, Sindou M, Mertens P, Berard J. Selective dorsal rhizotomy in children with cerebral palsy. Results in 18 cases at one year postoperatively. Stereotact Funct Neurosurg 1997; 69: 259-267.
19. Mall V, Heinen F, Kirschner J, et al. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure. J Child Neurol 2000; 15: 214-217.
20. McGibbon NH, Andrade CK, Widener G, Cintas HL. Effect of an equine-movement therapy program on gait, energy expenditure, and motor function in children with spastic cerebral palsy: a pilot study. Dev Med Child Neurol 1998; 40: 754-762.
21. McLaughlin JF, Bjornson KF, Astley SJ, et al. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 1998; 40: 220-232.
22. Montgomery D, Goldberg J, Amar M, et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med 1999; 26: 235-242.
23. Riedel M, Kraemer M, Lohse-Busch H, et al. Rehabilitation bei Kindern mit zerebralen Bewegungsstörungen mit den Mitteln der Manuellen Medizin - Erste Ergebnisse des "Gross Motor Function Measure". Phys Rehab Kur Med 1999; 9:184-186 (in German).
24. Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 1997; 39: 178-184.
25. Steinbok P, Reiner A, Kestle JR. Therapeutic electrical stimulation following selective posterior rhizotomy in children with spastic diplegic cerebral palsy: a randomized clinical trial. Dev Med Child Neurol 1997; 39: 515-520.
26. Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 1998; 40: 239-247.
27. Nordmark E, Jarnlo GB, Hagglund G. Comparison of the Gross Motor Function Measure and Paediatric Evaluation of Disability Inventory in assessing motor function in children undergoing selective dorsal rhizotomy. Dev Med Child Neurol 2000; 42:245-252.
28. Bloom KK, Nazar GB. Functional assessment following selective posterior rhizotomy in spastic cerebral palsy. Childs Nerv Syst 1994; 10: 84-86.
29. Dudgeon BJ, Libby AK, McLaughlin JF, Bjornson KF, Roberts TS. Prospective measurement of functional changes after selective dorsal rhizotomy. Arch Phys Med Rehabil 1994; 75: 46-53.
30. Fehlings D, Rang M, Glazier J, Steele J. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000; 137: 331-337.
31. McCarthy ML, Silberstein CE, Atkins EA, Harryman SE, Sponseller PD, Hadley-Miller NA. Comparing reliability and validity of pediatric instruments for measuring health and well-being of children with spastic cerebral palsy. Dev Med Child Neurol 2002; 44: 468-476.
32. Butler C, Chambers H, Goldstein M, et al. Evaluating research in developmental disabilities: a conceptual framework for reviewing treatment outcomes. Dev Med Child Neurol 1999; 41: 55-59.
33. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-223.